Ministry of Education
Vivek Vyas
VIDWAN ID: 348654

Dr Vivek Vyas

Male Doctor of Philosophy
Assistant Professor (Grade-III) | Institute of Pharmacy
Nirma University
Gujarat
Expertise: Medicinal Chemistry
ORCID 0000-0002-7800-0647 Scopus 24923859600 ResearcherID ABA-1084-2020 Google Scholar VWw5MdEAAAAJ
View older version My Dashboard
87 Publications
4 Projects
1449 Scopus Citations
1592 CrossRef
17 Years 9 Months Total Experience
Publications
87 Total
Articles
87
Activity

No publication activity to display.

Scopus Scopus
1,449 Citations
19 h-index
CrossRef CrossRef
1,592 Citations
21 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

Awarded with ACS (American Chemical Society) Best Abstract Award
2020
Ramanbhai Foundation 9th International Symposium organized by Zydus Research Center Ahmedabad
felicitation award on the foundation day celebration (1st October, 2022
2022
Institute of Pharmacy, Nirma University
felicitation award on the foundation day celebration (1st October, 2017
2017
Institute of Pharmacy, Nirma University
Best Assistant Professor of the Institute for Overall performance in Research, Academics and Admiration
2015
Nirma University, Ahmedabad

Community & Membership

No Data Found

There is currently nothing to display here.

Association of Pharmaceutical Teachers of India (APTI)
Life Member
Jan 2012
Indian Society of Chemist and Biologist (ISCB)
Life Member
Jan 2014
American Chemical Society
Member
Jan 2020
Indian Society for Technical Education (ISTE)
Life Member
Jan 2016
Society of Pharmaceutical Education & Research (SPER)
Life Member
Jan 2026
Indian Pharmacy Graduates' Association
Life Member
Jan 2012

Personal Details

Doctor of Philosophy
2014
N/A
Master of Pharmacy
2008
Homi Bhabha National Institute, Mumbai
Bachelor of Pharmacy
2005
Homi Bhabha National Institute, Mumbai
Assistant Professor (Grade-III)
Dec 2008 – Present
Nirma University | Institute of Pharmacy
Medical and Health Sciences
Medicinal Chemistry

Related Profiles

Scholarly Work

Targeting Malaria using Potent Plasmodium Falciparum Dihydroorotate Dehydrogenase (PfDHODH) Inhibitors Based on The Fused Ring Heterocyclic Compounds
Other
Agency: Indian Council of Medical Research Role: Principal Investigator Grant: IIRP-2023-2062/F1
Amount: ₹39.78 Lac
Duration: 2024 – Ongoing
Design, Synthesis and Biological Screening of Some Novel Casein Kinase-Ii Inhibitors as Anticancer Agents
Completed
Role: Principal Investigator
Amount: ₹2 Lac
Duration: 2021 – 2023
Exploring Heterocyclic Scaffolds as Telomerase Inhibitors for The Treatment of Cancer
Completed
Role: Co-Principal Investigator
Amount: ₹30 Lac
Duration: 2021 – 2024
Design And Synthesis of Quinoline Derivatives as Novel Apoptosis Inducers and Anticancer Agents
Completed
Role: Principal Investigator
Amount: ₹6.55 Lac
Duration: 2015 – 2018

Design Synthesis and Biological Evaluation of Novel Plasmodium Falciparum Dihydroorotate Dehydrogenase PfDHODH Inhibitors as Antimalarial Agents

University Institute of Pharmacy, Nirma University
Year 2026
Downloads 0
No Data Found

There is currently nothing to display here.

Scholarly Publications

Design and synthesis of potent N-phenylpyrimidine derivatives for the treatment of skin cancer

Journal Article
RSC Advances. Year: 2016. Volume: 6 , Issue: 13 , Pages: 10285-10297 .
Authors: Chaube, U.J.; Vyas, V.K.; Bhatt, H.G.
DOI 10.1039/c5ra27017k Crossref Crossref: 12 Scopus Scopus: 11

Capillary electrophoresis methods for impurity profiling of drugs: A review of the past decade

Open Access
Review
Journal of Pharmaceutical Analysis. Year: 2022. Volume: 12 , Issue: 1 , Pages: 15-28 .
Authors: Mansi Shah; Nrupesh Patel; Nagja Tripathi; Vivek K. Vyas
DOI 10.1016/j.jpha.2021.06.009 Crossref Crossref: 46 Scopus Scopus: 45

An innovative impurity profiling of Avanafil using LC and LC-MS/MS with in-silico toxicity prediction

Open Access
Journal Article
Arabian Journal of Chemistry. Year: 2020. Volume: 13 , Issue: 8 , Pages: 6493-6509 .
Authors: Mital, P.; Charmy, K.; Vivek, V.
DOI 10.1016/j.arabjc.2020.06.007 Crossref Crossref: 12 Scopus Scopus: 12

Neuroprotective Effects of Ethyl Pyruvate against Aluminum Chloride-Induced Alzheimer’s Disease in Rats via Inhibiting Toll-Like Receptor 4

Journal Article
Journal of Molecular Neuroscience. Year: 2020. Volume: 70 , Issue: 6 , Pages: 836-850 .
Authors: Vijaya Durga Chavali; Milee Agarwal; Vivek Kumar Vyas; Bhagawati Saxena
DOI 10.1007/s12031-020-01489-9 Crossref Crossref: 44 Scopus Scopus: 51

Effects of eugenol on the behavioral and pathological progression in the MPTP-induced Parkinson's disease mouse model.

Journal Article
Drug Discoveries & Therapeutics. Year: 2022. Volume: 16 , Issue: 4 , Pages: 154-163 .
Authors: Bhagawati Saxena
DOI 10.5582/ddt.2022.01026 Crossref Crossref: 28

Therapeutic potential of snake venom in cancer therapy: Current perspectives

Open Access
Journal Article
Asian Pacific Journal of Tropical Biomedicine. Year: 2013. Volume: 3 , Issue: 2 , Pages: 156-162 .
Authors: Vyas, V.K.; Brahmbhatt, K.; Bhatt, H.; Parmar, U.
DOI 10.1016/S2221-1691(13)60042-8 Crossref Crossref: 116 Scopus Scopus: 118

Evolution of Telomerase Inhibitors: A Review on Key Patents from 2015 to 2023

Open Access
Journal Article
CHEMISTRYSELECT. Year: 2024. Volume: 9 , Issue: 47 , Pages: e202404444 .
Authors: Rajdeep Dey; Keerti Vishwakarma; Bhumika Patel; Vivek K. Vyas; Hardik Bhatt
DOI 10.1002/slct.202404444 Crossref Crossref: 6 Scopus Scopus: 7

Investigation on Anti-plasmodial Agents Against wild-type PfDHFR Through In Silico Computational Tools

Journal Article
CHEMISTRYSELECT. Year: 2024. Volume: 9 , Issue: 28 , Pages: e202304151 .
Authors: Parikh, R.V.; Pandya, D.V.; Salaria, P.; Amarendar Reddy, M.; Vyas, V.K.; Bhatt, H.G.; Dhameliya, T.M.
DOI 10.1002/slct.202304151 Crossref Crossref: 5 Scopus Scopus: 6
Showing 1 to 8 of 87 publications